Monograph Capital

ODAIA Intelligence Inc. is a Canadian company that specializes in developing an artificial intelligence-based platform for customer engagement analysis. Founded in 2018 and headquartered in Toronto, ODAIA offers a cloud-based software as a service (SaaS) platform that enables enterprise clients to automate the mapping of customer touchpoints and journeys. Utilizing advanced techniques in big data mining, process journey mapping, and machine learning, the platform provides insights into customer behavior, predicts future actions, and identifies potential churn. ODAIA simplifies data ingestion and normalization from various sources, offering an intuitive dashboard for visualizing insights and predictions. The company was established by a team of academics and industry professionals, including members from the University of Toronto and the University of Lausanne, whose research has been widely recognized in the field.

MiroBio Ltd is a biotechnology company based in Oxford, United Kingdom, focused on developing antibody modulators for immune cell receptors aimed at treating autoimmune diseases. Founded in 2018, MiroBio leverages pioneering research from the University of Oxford to understand how immune cells communicate and are activated. This foundational knowledge allows the company to create innovative antibodies that stimulate specific immune cell signals, harnessing the body's natural control mechanisms to restore balance within the immune system. By activating these natural pathways, MiroBio's therapeutics aim to provide significant benefits to patients suffering from various autoimmune conditions, enabling clinicians to effectively manage overactive immune responses associated with these diseases.

AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.